These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7087040)

  • 1. Effects of bendroflumethiazide on urate metabolism during treatment of patients with renal stones.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Odlind B; Wikström B
    J Urol; 1982 Jun; 127(6):1207-10. PubMed ID: 7087040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
    Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström
    Br J Urol; 1979 Jun; 51(3):175-80. PubMed ID: 465983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1982 Mar; 127(3):589-92. PubMed ID: 7062444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of urate in patients with calcium stone disease.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    Nephron; 1982; 31(1):31-6. PubMed ID: 7110473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
    Jorgensen FS; Brünner S
    Scand J Urol Nephrol; 1974; 8(2):128-31. PubMed ID: 4838924
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L; Hellgren E
    Br J Urol; 1984 Jun; 56(3):255-62. PubMed ID: 6399984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uricemia and urinary acidification in renal calcium stone disease.
    Fellström B; Backman U; Danielson BG; Johansson G; Ljunghall S; Wikström B
    J Urol; 1983 Feb; 129(2):256-9. PubMed ID: 6834482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urate metabolism and renal calcium stone disease.
    Fellström B
    Scand J Urol Nephrol Suppl; 1981; 62():1-59. PubMed ID: 6960474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria.
    Gambaro G; Vincenti M; Marchini F; D'Angelo A; Baggio B
    Clin Sci (Lond); 1993 Jul; 85(1):41-4. PubMed ID: 8149692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic hypercalciuria. Urate and other ions in urine before and on various long term treatments.
    Gill HS; Rose GA
    Urol Res; 1985; 13(6):271-5. PubMed ID: 4095826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on circadian periodicity of serum and urinary urate in healthy Indians and renal stone formers.
    Singh RK; Bansal A
    Prog Clin Biol Res; 1987; 227B():305-13. PubMed ID: 3628342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate metabolism in primary hyperparathyroidism.
    Ljunghall S; Akerström G
    Urol Int; 1982; 37(2):73-8. PubMed ID: 7112764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria.
    Mateos Antón F; Puig JG; Gaspar G; Muñoz Sanz A; Herrero E; Ramos T; Martínez ME; Gómez Mantilla JM
    Nephron; 1984; 37(2):123-7. PubMed ID: 6728086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of renal excretion of uric acid during long-term thiazide therapy.
    Pak CY; Tolentino R; Stewart A; Galosy RA
    Invest Urol; 1978 Nov; 16(3):191-3. PubMed ID: 711411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urate and calcium stones--picking up a drop of mercury with one's fingers?
    Ryall RL; Grover PK; Marshall VR
    Am J Kidney Dis; 1991 Apr; 17(4):426-30. PubMed ID: 2008911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent thiazide therapy in recurrent stone formers.
    Rundle JS; Scott R
    Urology; 1980 Nov; 16(5):464-6. PubMed ID: 7445281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thiazides on the urinary calcium oxalate stone-forming potential in normal males.
    Brocks P; Christiansen C; Dirksen H; Transbøl I; Wolf H
    Scand J Urol Nephrol; 1983; 17(3):325-8. PubMed ID: 6648380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.